Modifier Q0 is a HCPCS Level II modifier used to identify an investigational clinical service furnished during an approved clinical research study.

The modifier is primarily used for Medicare beneficiaries participating in approved clinical trials, including FDA Investigational Device Exemption (IDE) studies and certain Coverage with Evidence Development (CED) studies.

Modifier Q0 was introduced on January 1, 2008, replacing the former HCPCS modifiers QA and QR. It identifies services that are themselves the subject of the clinical investigation, rather than routine medical care.

Modifier

Q0 (Q followed by the numeral zero)

Modifier Name

Investigational Clinical Service Provided in a Clinical Research Study That Is in an Approved Clinical Research Study

Plain English Explanation

Modifier Q0 tells Medicare:

“This service or item is the investigational treatment being studied in an approved clinical research trial.”

Purpose

Modifier Q0 is used to:

Identify investigational services.
Distinguish investigational services from routine clinical care.
Support Medicare clinical trial billing.
Identify FDA IDE services.
Support Coverage with Evidence Development (CED) claims.

Understanding Modifier Q0

An investigational clinical service is:

The actual item or service being studied.
The primary objective of the research protocol.
A service that may be FDA-approved, non-approved, experimental, or otherwise under investigation.

Examples include:

Investigational cardiac devices
Experimental implantable devices
Investigational medications
New surgical technologies
Novel diagnostic procedures being evaluated in an approved clinical trial

Modifier Q0 identifies the investigational service itself—not the routine care surrounding the trial.

When to Use Modifier Q0

Append Modifier Q0 when:

The service is investigational.
The study is an approved clinical research study.
Medicare permits billing for the investigational service.
The service is performed under an approved IDE or other Medicare-recognized clinical research study.

Examples include:

Service	Example
Category B IDE device implantation	Investigational device
Coverage with Evidence Development (CED) services	Medicare-approved registry study
Investigational procedures	Clinical trial protocol
Experimental medical technologies	Approved Medicare research study

When NOT to Use Modifier Q0

Do not use Modifier Q0 when:

The service is routine patient care.
The patient is not enrolled in an approved clinical research study.
The service is unrelated to the investigational objective.
The payer does not recognize Medicare clinical trial billing rules.

Routine clinical services furnished during the trial are generally reported with Modifier Q1, not Q0.

Medicare Rules

Medicare requires:

The clinical research study must qualify under Medicare policy.
Modifier Q0 identifies the investigational clinical service.
Clinical trial claims generally include:
- Modifier Q0 (for investigational services)
- Appropriate clinical trial diagnosis code Z00.6
- Clinical Trial Number (National Clinical Trial/NCT number or IDE number, when applicable)
For Category B IDE claims, report the IDE number on the claim in addition to Modifier Q0.

Commercial Insurance Rules

Commercial payer requirements vary.

Some commercial insurers:

Follow Medicare clinical trial policies.
Require prior authorization.
Require study approval documentation.
Require payer-specific research billing procedures.

Always verify payer-specific requirements.

Documentation Requirements

Documentation should include:

Clinical trial protocol.
Proof the study is approved.
Investigator documentation.
Patient informed consent.
Clinical Trial Number (NCT) or IDE number, when applicable.
Medical necessity.
Complete clinical documentation.
Provider signature.

Real Billing Examples

Example 1 – Category B IDE Device

A Medicare beneficiary receives an investigational cardiac device under an FDA-approved Category B IDE study.

Billing

Appropriate HCPCS/CPT code
Modifier Q0
IDE number
Clinical trial number (if required)
ICD-10-CM Z00.6

Example 2 – Coverage with Evidence Development

A beneficiary participates in a Medicare-approved registry evaluating a new treatment.

Billing

Appropriate procedure code
Modifier Q0

Example 3 – Investigational Drug Administration

An investigational medication is administered as the primary intervention in an approved study.

Billing

Appropriate HCPCS code
Modifier Q0

Example 4 – Investigational Surgical Procedure

A new surgical technology is being evaluated under an approved Medicare clinical trial.

Billing

Appropriate CPT code
Modifier Q0

Example 5 – Incorrect Billing

A routine office visit for blood pressure follow-up is billed with Modifier Q0 even though it is not part of a clinical trial.

This is incorrect because the service is not investigational.

CMS-1500 Claim Example

Field	Example
CPT/HCPCS	Appropriate investigational service
Modifier	Q0
Diagnosis	Z00.6 plus condition being treated
Item 19/23	Clinical Trial Number or IDE Number (when applicable)
Units	1

Common Denials

Patient not enrolled in an approved clinical trial.
Missing Modifier Q0.
Missing clinical trial number.
Missing IDE number.
Missing diagnosis code Z00.6.
Service not investigational.
Incomplete documentation.

Correcting Denials

Verify study approval.
Confirm the service is investigational.
Add Modifier Q0.
Include the required Clinical Trial Number or IDE number.
Report Z00.6 when applicable.
Submit a corrected claim with supporting documentation.

Coding Tips

Remember: Q0 = Investigational Service.
Q1 = Routine Clinical Service in the same approved clinical trial.
Report the required Clinical Trial Number or IDE number when applicable.
Maintain complete research documentation.
Review CMS clinical trial billing updates regularly.

Modifier Q0 vs Modifier Q1

Modifier	Description
Q0	Investigational clinical service
Q1	Routine clinical service provided during an approved clinical trial

Modifier Q0 vs Modifier QW

Modifier	Description
Q0	Investigational clinical service
QW	CLIA-waived laboratory test

Modifier Q0 vs Modifier 95

Modifier	Description
Q0	Clinical research study
95	Telehealth audio-video service

Frequently Asked Questions (FAQs)

Q1. What does Modifier Q0 mean?

Answer: It identifies an investigational clinical service provided during an approved clinical research study.

Q2. What is the difference between Q0 and Q1?

Answer: Q0 identifies the investigational service being studied, while Q1 identifies routine clinical care provided during participation in the same approved clinical trial.

Q3. Is Z00.6 reported with Q0?

Answer: Yes. Medicare clinical trial claims commonly include ICD-10-CM Z00.6 (Encounter for examination for normal comparison and control in clinical research program) along with the condition being treated, when applicable.

Q4. Is a Clinical Trial Number required?

Answer: Yes. Medicare requires the appropriate Clinical Trial Number (NCT) or IDE number, depending on the type of approved research study.

Q5. Can commercial insurance require Modifier Q0?

Answer: Some commercial payers recognize Modifier Q0, but requirements vary by payer and contract.

AR Caller Tips

When following up on Q0 claims:

Verify enrollment in an approved clinical trial.
Confirm the service is investigational.
Check that Modifier Q0 is present.
Verify the Clinical Trial Number or IDE number.
Confirm diagnosis code Z00.6 when applicable.
Record payer reference numbers and appeal instructions.

Interview Questions

Question 1

What does Modifier Q0 identify?

Answer: An investigational clinical service furnished in an approved clinical research study.

Question 2

What is the difference between Q0 and Q1?

Answer: Q0 identifies the investigational service, while Q1 identifies routine patient care during the clinical trial.

Question 3

What diagnosis code is commonly reported with Q0 claims?

Answer: ICD-10-CM Z00.6, when applicable to Medicare clinical trial billing.

Question 4

When is an IDE number required?

Answer: For applicable FDA Category B Investigational Device Exemption (IDE) studies.

Practice Scenario

Scenario

A Medicare beneficiary receives an investigational implantable cardiac device as part of an FDA-approved Category B IDE clinical trial.

Question

How should the claim be billed?

Answer

Report:

Appropriate CPT/HCPCS code
Modifier Q0
ICD-10-CM Z00.6
Applicable IDE Number and Clinical Trial Number, when required

This identifies the service as the investigational item being studied.

Related Medicare Special Modifiers

Q1 – Routine Clinical Service Provided in an Approved Clinical Research Study
QW – CLIA Waived Test
Q6 – Locum Tenens Physician
Q5 – Reciprocal Billing Arrangement

Common Billing Mistakes

Using Q0 for routine office visits.
Omitting the Clinical Trial Number or IDE number.
Missing diagnosis code Z00.6 when applicable.
Confusing Q0 with Q1.
Billing services outside an approved clinical trial.

Key Takeaways

Modifier Q0 identifies investigational clinical services in approved clinical research studies.
It differs from Modifier Q1, which is used for routine clinical care during the trial.
Medicare clinical trial claims often require Z00.6, the Clinical Trial Number, and/or an IDE number.
Accurate documentation is essential for compliant billing and reimbursement.
Always follow current CMS clinical trial billing guidance.

References

CMS MLN Matters MM5805 – New HCPCS Modifiers for Clinical Research Studies.
CMS Medicare Claims Processing Manual, Chapter 32 – Clinical Trials and IDE Billing.
Noridian Medicare – Modifier Q0 Guidance.
HCPCS Level II Code Book.
CPT® Professional Edition (American Medical Association).

Conclusion

Modifier Q0 is a specialized Medicare HCPCS modifier used to identify investigational clinical services furnished during an approved clinical research study. It plays a critical role in Medicare clinical trial billing by distinguishing investigational services from routine patient care. Proper reporting requires compliance with CMS clinical trial policies, inclusion of required clinical trial identifiers, and thorough documentation to support coverage and reimbursement.

Educational Disclaimer

This article was prepared with the assistance of artificial intelligence (AI) for educational and informational purposes. It is based on publicly available CMS guidance, Medicare clinical trial policies, HCPCS Level II guidance, and general medical billing principles. It is not an official publication of CMS or the American Medical Association (AMA). Always consult the latest CMS Medicare Claims Processing Manual, Medicare National Coverage Determination (NCD) 310.1, HCPCS Level II Code Book, CPT® Professional Edition, and payer-specific billing policies before coding, billing, or submitting claims.